Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability

Bias in meta-analysis detected by a simple, graphical test

Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722

Meta-analysis in clinical trials

DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552

Book Reviews: Statistical Methods for Meta-Analysis Larry V. Hedges and Ingram Olkin New York: Academic Press, 1985. xxii + 369 pp

Wasserman, S. S., Hedges, L. V., & Olkin, I. (1988) · Journal of Educational Statistics · doi:10.2307/1164953 · Cited by 10,377

Research Diagnostic Criteria

Spitzer, R. L. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770300115013 · Cited by 6,946

Diagnostic criteria for use in psychiatric research.

Feighner, J. P., Robins, E., Guze, S. B., Woodruff, R. A., Winokur, G., & Munoz, R. A. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750190059011 · Cited by 5,491

Statistical Methods for Meta-Analysis.

Freeman, P. R., Hedges, L. V., & Olkin, I. (1986) · Biometrics · doi:10.2307/2531069 · Cited by 4,840

Research Diagnostic Criteria

Spitzer, R. L., Endicott, J., & Robins, E. (1978) · PsycTESTS Dataset · doi:10.1037/t04137-000 · Cited by 556

Recognition and management of depression in general practice: consensus statement

Paykel, E. S., & Priest, R. G. (1992) · BMJ · doi:10.1136/bmj.305.6863.1198 · Cited by 540

Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.

Song, F., Freemantle, N., Sheldon, T. A., House, A., Watson, P., Long, A., & Mason, J. (1993) · BMJ · doi:10.1136/bmj.306.6879.683 · Cited by 399

Paroxetine: A selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study

Danish University Antidepressant Group (1990) · Journal of Affective Disorders · doi:10.1016/0165-0327(90)90081-i · Cited by 398

Pharmacokinetics and Efficacy of Fluvoxamine and Amitriptyline in Depression

Vezmar, S., Miljković, B., Vučićević, K. M., Timotijević, I., Prostran, M. S., Todorović, Z., & Pokrajac, M. (2009) · Journal of Pharmacological Sciences · doi:10.1254/jphs.09013fp · Cited by 25

Screening, diagnosis, and treatment of depression.

Greenberg, J., Tesfazion, A. A., & Robinson, C. S. (2012) · Military Medicine · doi:10.7205/milmed-d-12-00102 · Cited by 35

Antidepressants: Controversies about their efficacy in depression, their effect on suicidality and their place in a complex psychiatric treatment approach

Möller, H. (2009) · The World Journal of Biological Psychiatry · doi:10.1080/15622970903101665 · Cited by 24

Antidepressant use and glycemic control

Mojtabai, R. (2013) · Psychopharmacology · doi:10.1007/s00213-013-2972-5 · Cited by 24

Differential effects of NMDA receptor antagonism on spine density

Ruddy, R. M., Chen, Y., Milenkovic, M., & Ramsey, A. J. (2014) · Synapse · doi:10.1002/syn.21784 · Cited by 23

The South African Society of Psychiatrists (SASOP) Treatment Guidlelines for Psychiatric Disorders

Emsley, R. A., Flisher, A. J., Grobler, G. P., Seedat, S., & Szabo, C. P. (2013) · South African Journal of Psychiatry · doi:10.4102/sajpsychiatry.v19i3.942 · Cited by 25

How Should Mood Disorders be Modelled?

Parker, G. B. (2008) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670802345458 · Cited by 24

Antidepressant prescribing and changes in antidepressant poisoning mortality and suicide in England, 1993-2004

Morgan, O. W., Griffiths, C., & Majeed, A. (2008) · Journal of Public Health · doi:10.1093/pubmed/fdm085 · Cited by 24

Nondirecting Group sp3 C−H Activation for Synthesis of Bibenzyls via Homo‐coupling as Catalyzed by Reduced Graphene Oxide Supported PtPd@Pt Porous Nanospheres

Wang, Z., Lv, J., Yi, R., Xiao, M., Feng, J., Liang, Z., Wang, A., & Xu, X. (2017) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.201701389 · Cited by 24

The Charcot Effect: The Invention of Mental Illnesses

Álvarez, M. P., & García‐Montes, J. M. (2007) · Journal of Constructivist Psychology · doi:10.1080/10720530701503843 · Cited by 25

A new category of psychotropic drugs: neuroactive lipids as exemplified by ethyl eicosapentaenoate (E-E)

Horrobin, D. F. (2002) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8171-5_6 · Cited by 24

Are Selective Serotonin Reuptake Inhibitors Safe for Drivers? What is the Evidence?

Ravera, S., Ramaekers, J. G., den Berg, L. T. W. D. J., & de Gier, J. J. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2012.04.002 · Cited by 23

Do stress hormones connect environmental effects with behavior in the forced swim test?

Pintér, O., Domokos, Á., Mergl, Z., Mikics, É., & Zelena, D. (2011) · Endocrine Journal · doi:10.1507/endocrj.k10e-375 · Cited by 23

Desvenlafaxine in major depressive disorder: an evidence-based review of its place in therapy

Lieberman, D. Z. (2009) · Core evidence · doi:10.2147/ce.s5998 · Cited by 25

Escitalopram Efficacy in Depression

Bousman, C., Sarris, J. J., Won, E., Chang, H.-S., Singh, A., Lee, H.-Y., Ham, B., Tan, C., Lee, M.-S., & Ng, C. H. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000165 · Cited by 23

Pre-treatment with amitriptyline causes epigenetic up-regulation of neuroprotection-associated genes and has anti-apoptotic effects in mouse neuronal cells

Tran, N. Q. V., Nguyen, N. A., Takabe, K., Yamagata, Z., & Miyake, K. (2017) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2017.05.002 · Cited by 23

Therapieresistenz auf Antidepressiva

Møller, H. J. (2004) · Der Nervenarzt · doi:10.1007/s00115-004-1728-1 · Cited by 23

A Systematic Review of Pharmacologic Treatments for School Refusal Behavior

Londono Tobon, A., Reed, M. O., Taylor, J. H., & Bloch, M. H. (2018) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2017.0160 · Cited by 22

Comparison of paroxetine and amitriptyline as adjunct to lithium maintenance therapy in bipolar depression: A reanalysis of a randomized, double-blind study

Pilhatsch, M., Wolf, R., Winter, C., Lewitzka, U., & Bauer, M. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.04.025 · Cited by 22

Moderation of antidepressant and placebo outcomes by baseline severity in late-life depression: A systematic review and meta-analysis

Locher, C., Kossowsky, J., Gaab, J., Kirsch, I., Bain, P. A., & Krummenacher, P. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.03.062 · Cited by 23

TCA and SSRI Antidepressants Exert Selection Pressure for Efflux-Dependent Antibiotic Resistance Mechanisms in Escherichia coli

Ou, J., Elizalde, P., Guo, H., Qin, H., Tobe, B. T. D., & Choy, J. S. (2022) · mBio · doi:10.1128/mbio.02191-22 · Cited by 29

Development of electrospun nanofibers based on Poly (vinyl alcohol) for thin film solid-phase microextraction of antidepressant drugs in biological samples

Hosseini, F. S., Kharazmi, F., Davarani, S. S. H., & Ebrahimzadeh, H. (2023) · Journal of Chromatography A · doi:10.1016/j.chroma.2023.463984 · Cited by 22

Effect of aqueous extract and fractions of Zhi-Zi-Hou-Pu decoction against depression in inescapable stressed mice: Restoration of monoamine neurotransmitters in discrete brain regions

Yao, A.-M., Ma, F., Zhang, L., & Fang, F. (2012) · Pharmaceutical Biology · doi:10.3109/13880209.2012.717087 · Cited by 22

Adverse Event Reporting with Selective Serotonin-Reuptake Inhibitors

Hartnell, N. R., Wilson, J. P., Patel, N. C., & Crismon, M. L. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1c522 · Cited by 22

A Self-Controlled, Naturalistic Study of Selective Serotonin Reuptake Inhibitors versus Tricyclic Antidepressants

Faravelli, C., Cosci, F., Ciampelli, M., Scarpato, M. A., Spiti, R., & Ricca, V. (2003) · Psychotherapy and Psychosomatics · doi:10.1159/000068689 · Cited by 22

Antidepressants and benzodiazepines for panic disorder in adults

Guaiana, G., Barbui, C., Bighelli, I., Trespidi, C., Chiodo, D., Cipriani, A., Davies, S., & Koesters, M. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011567 · Cited by 23

Should rTMS be considered a first-line treatment for major depressive episodes in adults?

O’Sullivan, S. J., Buchanan, D. M., Batail, J.-M. V., & Williams, N. (2024) · Clinical Neurophysiology · doi:10.1016/j.clinph.2024.06.004 · Cited by 24

Agomelatine in depression

Smeraldi, E., & Delmonte, D. (2013) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2013.828690 · Cited by 22

Association between Serotonin Transporter-Linked Polymorphic Region and Escitalopram Antidepressant Treatment Response in Korean Patients with Major Depressive Disorder

Won, E., Chang, H.-S., Lee, H.-Y., Ham, B., & Lee, M.-S. (2012) · Neuropsychobiology · doi:10.1159/000341876 · Cited by 22

Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life

Seripa, D., Pilotto, A., Paroni, G., Fontana, A., D’Onofrio, G., Gravina, C., Urbano, M., Cascavilla, L., Paris, F., Panza, F., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115578159 · Cited by 23

Psychosocial Assessment of Functional Gastrointestinal Disorders in Clinical Practice

Williams, M. J. A., Budavari, A. I., Olden, K. W., & Jones, M. P. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000180637.82011.bb · Cited by 21

Involvement of Isoorientin in the Antidepressant Bioactivity of a Flavonoid-Rich Extract from Passiflora edulis f. flavicarpa Leaves

Alves, J. S. F., Marques, J. I., Demarque, D. P., Costa, L. R. F., Amaral, J. G., Lopes, N. P., da Silva-Júnior, A. A., Soares, L. A. L., Gavioli, E. C., Ferreira, L. D. S., et al. (2020) · Revista Brasileira de Farmacognosia · doi:10.1007/s43450-020-00003-x · Cited by 21

Augmentation with olanzapine in TCA‐refractory depression with melancholic features: a consecutive case series

Takahashi, H., Kamata, M., Yoshida, K., Higuchi, H., & Ishigooka, J. (2008) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.914 · Cited by 22

Remission from Depression

Han, D., & Wang, E. C. Y. (2005) · PharmacoEconomics · doi:10.2165/00019053-200523060-00004 · Cited by 21

Antidepressant treatment for depression: total charges and therapy duration

Dobrez, D. G., Melfi, C. A., Croghan, T. W., Kniesner, T. J., & Obenchain, R. L. (2000) · The Journal of Mental Health Policy and Economics · doi:10.1002/mhp.95 · Cited by 21

Geriatric mental health disaster and emergency preparedness

Toner, J. A., Therese, M., Mierswa, & Howe, J. L. (2010) · Medical Entomology and Zoology · Cited by 20

Frequency of depression among patients with neurocysticercosis

de Almeida, S. M., & Gurjão, S. A. (2010) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2010000100017 · Cited by 20

Strategies to achieve clinical effectiveness: Refining existing therapies and pursuing emerging targets

Kennedy, S. H., Young, A. H., & Blier, P. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.03.048 · Cited by 20

Mortality, disability, psychiatric treatment and medication in first-onset schizophrenia in Finland : the register linkage study

Kiviniemi, M. (2014) · Cited by 20

Sertraline-Cyclodextrin Complex Orodispersible Sublingual Tablet: Optimization, Stability, and Pharmacokinetics

Abouhussein, D. M. N., Nabarawi, M. A. E., Shalaby, S. H., & El-Bary, A. A. (2019) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-019-09416-1 · Cited by 20

Depressive Störungen: Major Depression und Dysthymie

Beesdo‐Baum, K., & Wïttchen, H. (2011) · Springer-Lehrbuch · doi:10.1007/978-3-642-13018-2_40 · Cited by 22

Double-blind comparison of fluoxetine and nortriptyline in the treatment of moderate to severe major depression

Akhondzadeh, S., Faraji, H., Sadeghi, M., Afkham, K., Fakhrzadeh, H., & Kamalipour, A. (2003) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.0269-4727.2003.00505.x · Cited by 20

Quantitative 1 H NMR spectroscopic determination of the E/Z isomer ratio of the antidepressant drug fluvoxamine for use in pharmaceutical analysis

Deubner, R., & Holzgrabe, U. (2002) · Magnetic Resonance in Chemistry · doi:10.1002/mrc.1101 · Cited by 20

Antidepressants

Nash, J. R., & Nutt, D. (2007) · Psychiatry · doi:10.1016/j.mppsy.2007.04.005 · Cited by 20

Design of mirtazapine solid dispersion with different carriers’ systems: optimization, in vitro evaluation, and bioavailability assessment

Aldeeb, R. A. E., Mahdy, M. A., El-Nahas, H. M., & Musallam, A. A. (2023) · Drug Delivery and Translational Research · doi:10.1007/s13346-023-01316-9 · Cited by 19

Pharmacological treatment of unipolar depression during pregnancy and breast-feeding—A clinical overview

Nielsen, R. E., & Damkier, P. (2012) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2011.650198 · Cited by 19

Has electroconvulsive therapy use remained stable over time? A decade of electroconvulsive therapy service provision in Victoria, Australia

Plakiotis, C., George, K., & O’Connor, D. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412440190 · Cited by 19

Analysing duration of episodes of pharmacological care: an example of antidepressant use in Danish general practice

Gichangi, A., Andersen, M. T., Kragstrup, J., & Vach, W. (2005) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1160 · Cited by 19

Trends in the Prescribing of Antidepressants Following Acute Myocardial Infarction, 1993–2002

Benazon, N. R., Mamdani, M., & Coyne, J. C. (2005) · Psychosomatic Medicine · doi:10.1097/01.psy.0000188399.80167.aa · Cited by 20

Efficacy and tolerability of controlled-release paroxetine in the treatment of severe depression: Post hoc analysis of pooled data from a subset of subjects in four double-blind clinical trials

Dünner, D. L., Lipschitz, A., Pitts, C. D., & Davies, J. T. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.12.013 · Cited by 19

Clinical overview of NMDA-R antagonists and clinical practice

Davoudian, P. A., & Wilkinson, S. T. (2020) · Advances in pharmacology · doi:10.1016/bs.apha.2020.04.004 · Cited by 19

The Small Specific Effects of Antidepressants in Clinical Trials: What Do They Mean to Psychiatrists?

Thase, M. E. (2011) · Current Psychiatry Reports · doi:10.1007/s11920-011-0235-x · Cited by 20

Using time-series intervention analysis to understand U.S. Medicaid expenditures on antidepressant agents

Ferrand, Y., Kelton, C. M. L., Guo, J. J., Levy, M. S., & Yu, Y. (2010) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2009.12.002 · Cited by 18

Antidepressant Prescribing Patterns in Korea: Results from the Clinical Research Center for Depression Study

Bae, K., Kim, S., Kim, J. M., Shin, I., Yoon, J., Jung, S.-W., Lee, M., Yim, H. W., & Jun, T. (2011) · Psychiatry Investigation · doi:10.4306/pi.2011.8.3.234 · Cited by 18

Identifying drugs needing pharmacogenetic monitoring in a Korean hospital

Kim, Y. M., Yoo, S. H., Kang, R. Y., Kim, M. J., Bae, Y. Y., Lee, Y. K., Jeon, S. J., Chon, K. J., Shin, S. M., Kim, S. G., et al. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp050490 · Cited by 18

Randomized Controlled Trials in Psychiatry. Part 1: Methodology and Critical Evaluation

Porter, R., Frampton, C. M., Joyce, P. R., & Mulder, R. (2003) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2003.01175.x · Cited by 18

Reinventing the Wheel Will Not Make It Rounder: Controlled Trials of Homeopathy Reconsidered

Walach, H. (2003) · The Journal of Alternative and Complementary Medicine · doi:10.1089/107555303321222865 · Cited by 18

The Relationship Between Adverse Events During Selective Serotonin Reuptake Inhibitor Treatment for Major Depressive Disorder and Nonremission in the Suicide Assessment Methodology Study

Daly, E., Trivedi, M. H., D, M. F. M., Shelton, R. C., Wisniewski, S. R., Morris, D. W., Stegman, D., Preskorn, S., & Rush, A. J. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318205e17b · Cited by 17

Psychopharmacological treatments in HIV patients under antiretroviral therapy.

Gallego, L., Barreiro, P., & López-Ibor, J. J. (2012) · PubMed · Cited by 17

A randomized, placebo-controlled, double-blind study on the effects of SZL on patients with mild to moderate depressive disorder with comparison to fluoxetine

Hu, Y., Wang, Y., Chen, C., Yang, W., Zhu, W., Wang, Y., & Liu, P. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114549 · Cited by 17

α2 Adrenergic Receptor Trafficking as a Therapeutic Target in Antidepressant Drug Action

Cottingham, C., Ferryman, C. J., & Wang, Q. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.03.007 · Cited by 17

Effects of Chronic Citalopram Treatment on Central and Peripheral Spontaneous Open‐Field Behaviours in Rats

Kugelberg, F. C., Apelqvist, G., & Bengtsson, F. (2002) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2002.900603.x · Cited by 17

Meta-analyses: a method to maximise the evidence from clinical studies?

Maier, W., & Möller, H. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-009-0068-3 · Cited by 19

Fluoxetine Chronic Treatment Inhibits Male Rat Sexual Behavior by Affecting Both Copulatory Behavior and the Genital Motor Pattern of Ejaculation

Hueletl-Soto, M. E., Carro-Juárez, M., & Rodrı́guez–Manzo, G. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02339.x · Cited by 17

Unmet needs in the pharmacological management of depression

Baldwin, D. S. (2001) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.337 · Cited by 17

Evidence-Based, Pharmacological Treatment Guideline for Depression in Korea, Revised Edition

Won, E., Park, S., Han, K.-M., Sung, S.-H., Lee, H.-Y., Paik, J., Jeon, H. J., Lee, M., Shim, S.-H., Ko, Y., et al. (2014) · Journal of Korean Medical Science · doi:10.3346/jkms.2014.29.4.468 · Cited by 17

Effects of myo-Inositol Versus Fluoxetine and Imipramine Pretreatments on Serotonin 5HT2A and Muscarinic Acetylcholine Receptors in Human Neuroblastoma Cells

Brink, C. B., Viljoen, S. L., de Kock, S. E., Stein, D. J., & Harvey, B. H. (2004) · Metabolic Brain Disease · doi:10.1023/b:mebr.0000027417.74156.5f · Cited by 17

Sertraline versus other antidepressive agents for depression

Cipriani, A., Ferla, T. L., Furukawa, T. A., Signoretti, A., Nakagawa, A., Churchill, R. C., McGuire, H., & Barbui, C. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006117.pub3 · Cited by 18

A mindful yoga intervention for young women with major depressive disorder: Design and baseline sample characteristics of a randomized controlled trial

Vollbehr, N. K., Hoenders, H. J. R., Bartels‐Velthuis, A. A., Nauta, M. H., Castelein, S., Schroevers, M. J., Stant, A. D., de Jong, P. J., & Ostafin, B. D. (2020) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1820 · Cited by 16

G protein-biased LPAR1 agonism of prototypic antidepressants: Implication in the identification of novel therapeutic target for depression

Kajitani, N., Okada‐Tsuchioka, M., Inoue, A., Miyano, K., Masuda, T., Boku, S., Iwamoto, K., Ohtsuki, S., Uezono, Y., Aoki, J., et al. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01727-9 · Cited by 16

A double-blind randomized study comparing plasma level-targeted dose imipramine and high-dose venlafaxine in depressed inpatients

Vermeiden, M., Mulder, P. G. H., van den Broek, W. W., Bruijn, J. A., & Birkenhäger, T. K. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.029 · Cited by 16

Use of psychotropic drugs in Lombardy in time of economic crisis (2007–2011): A population-based study of adult employees

Vittadini, G., Beghi, M., Mezzanzanica, M., Ronzoni, G., & Cornaggia, C. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.06.006 · Cited by 16

Antidepressant Drugs

Howard, P. D., Twycross, R., Shuster, J. L., Mihalyo, M., & Wilcock, A. (2012) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2012.09.001 · Cited by 21

Transcultural Issues in Mood and Anxiety Disorders: A Focus on Japan

Radford, M. (2004) · CNS Spectrums · doi:10.1017/s1092852900025451 · Cited by 8

Managing Mental Health Conditions in Primary Care Settings

Hackley, B. K., Sharma, C., Kedzior, A., & Sreenivasan, S. (2009) · Journal of Midwifery & Women s Health · doi:10.1016/j.jmwh.2009.06.004 · Cited by 16

Efficacy of venlafaxine compared with tricyclic antidepressants in depressive disorder: a meta-analysis

van den Broek, W. W., Mulder, P., van Os, E., Birkenhäger, T., Pluijms, E. M., & Bruijn, J. A. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108089821 · Cited by 16

Approach to menopausal symptoms in women with breast cancer

Stearns, V., & Hayes, D. F. (2002) · Current Treatment Options in Oncology · doi:10.1007/s11864-002-0064-6 · Cited by 16

Pharmacogenetics of Monoamine Transporters

Glatt, C. E., & Reus, V. I. (2003) · Pharmacogenomics · doi:10.1517/phgs.4.5.583.23789 · Cited by 16

Developing More Efficacious Antidepressant Medications: Improving and Aligning Preclinical and Clinical Assessment Tools

Cryan, J. F., Sánchez, C., Dinan, T. G., & Borsini, F. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373861-5.00007-2 · Cited by 17

Future Thinking and Depression

Sarkohi, A. (2011) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 16

What Is the Role of Medications in Late Life Depression?

Kok, R. (2013) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2013.08.006 · Cited by 18

Neuroprotective Effect of Paroxetine on Memory Deficit Induced by Cerebral Ischemia after Transient Bilateral Occlusion of Common Carotid Arteries in Rat.

Naderi, Y., Parvardeh, S., Zanjani, T. M., & Sabetkasaei, M. (2018) · Europe PMC (PubMed Central) · Cited by 15

Antidepressant drug paroxetine blocks the open pore of Kv3.1 potassium channel

Lee, H. M., Chai, O. H., Hahn, S. J., & Choi, B. H. (2017) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2018.22.1.71 · Cited by 15

The accordion phenomenon

Davidavičius, G., Manoharan, G., & Bruyne, B. D. (2005) · Heart · doi:10.1136/hrt.2004.040832 · Cited by 15

Cost Effectiveness of Venlafaxine Compared with Generic Fluoxetine or Generic Amitriptyline in Major Depressive Disorder in the UK

Lenox‐Smith, A., Greenstreet, L., Burslem, K., & Knight, C. (2009) · Clinical Drug Investigation · doi:10.2165/00044011-200929030-00004 · Cited by 15

Prevalence and sociodemographic patterns of antidepressant use among women of reproductive age: A prescription database study

Wemakor, A., Casson, K., & Dolk, H. M. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.06.015 · Cited by 15

HEALTHCARE EXPENDITURE IN PATIENTS TREATED WITH VENLAFAXINE OR SELECTIVE SEROTONIN REUPTAKE INHIBITORS FOR DEPRESSION AND ANXIETY

Wan, G., Crown, W., Berndt, E. R., Finkelstein, S. N., & Ling, D. C. (2002) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2002.tb11293.x · Cited by 15

Medication for Behavior Modification in Birds

van Zeeland, Y. R. A. (2017) · Veterinary Clinics of North America Exotic Animal Practice · doi:10.1016/j.cvex.2017.08.005 · Cited by 14

Amitriptyline-molybdovanadate/-molybdotungstate based ion-selective membrane electrodes for determination of amitriptyline in pharmaceutical formulations and water samples

Rahman, N., & Khan, S. (2016) · Journal of Electroanalytical Chemistry · doi:10.1016/j.jelechem.2016.07.040 · Cited by 14

Effect of Problem-Solving Therapy Versus Supportive Management in Older Adults with Low Back Pain and Depression While on Antidepressant Pharmacotherapy

Karp, J. F., Gao, X., Wahed, A. S., Morse, J. Q., Rollman, B. L., Weiner, D. K., & Reynolds, C. F. (2018) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2018.01.004 · Cited by 14

Serotonin stimulated parathyroid hormone related protein induction in the mammary epithelia by transglutaminase-dependent serotonylation

Sheftel, C. M., & Hernandez, L. L. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241192 · Cited by 14

Therapy Strategies for Late-life Depression: A Review

Piel, C., & Quante, A. (2023) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000678 · Cited by 15

Pharmacotherapy compared to placebo for people with Bulimia Nervosa: A systematic review and meta-analysis

Argyrou, A., Lappas, A. S., Bakaloudi, D. R., Tsekitsidi, E., Mathioudaki, E., Michou, N., Polyzopoulou, Z. A., Christodoulou, G. N., Papazisis, G., Chourdakis, M., et al. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115357 · Cited by 17

Tricyclic antidepressants exhibit variable pharmacological profiles at the α2A adrenergic receptor

Cottingham, C., Percival, S. M., Birky, T. L., & Wang, Q. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.024 · Cited by 14

Blockade of HERG Human K+ Channels by the Antidepressant Drug Paroxetine

Lee, S. H., Sung, M. J., Lee, H. M., Chu, D., Hahn, S. J., Jo, S., Choe, H., & Choi, B. H. (2014) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b14-00244 · Cited by 14

Pharmacological Characterization of H05, a Novel Serotonin and Noradrenaline Reuptake Inhibitor with Moderate 5-HT2A Antagonist Activity for the Treatment of Depression

Xu, X., Wei, Y., Guo, Q., Zhao, S., Liu, Z., Xiao, T., Liu, Y., Qiu, Y., Hou, Y., Zhang, G., et al. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.248351 · Cited by 14

A systematic review and meta-analysis of trials of treatment of depression from India

Grover, S., & Sarkar, S. (2014) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.124711 · Cited by 14

Diretrizes da World Federation of Societies of Biological Psychiatry (WFSBP) para tratamento biológico de transtornos depressivos unipolares, 1ª parte: tratamento agudo e de continuação do transtorno depressivo maior

Bauer, M., Whybrow, P. C., Angst, J., Versiani, M., & Möller, H. (2009) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832009000800001 · Cited by 14

Evaluating fluvoxamine for the outpatient treatment of COVID‐19: A systematic review and meta‐analysis

Deng, J., Moskalyk, M., Zuo, Q., Garcia, M. C., Abbas, U., Ramaraju, H. B., Rayner, D. G., Park, Y., Heybati, K., Zhou, F., et al. (2023) · Reviews in Medical Virology · doi:10.1002/rmv.2501 · Cited by 12

A closer look at the 2019 Beers criteria

Sharma, R., Arora, M., Garg, R., & Bansal, P. (2020) · Drugs & Therapy Perspectives · doi:10.1007/s40267-019-00704-x · Cited by 13

Depression and associated anxiety in primary care: A double-blind comparison of paroxetine and amitriptyline

Stott, P., Blagden, M. D., & Aitken, C. A. (1993) · European Neuropsychopharmacology · doi:10.1016/0924-977x(93)90100-z · Cited by 21

SSRIs versus tricyclic antidepressants in depressed inpatients: A meta-analysis of efficacy and tolerability

Anderson, I. M. (1998) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1998)7:1+ · Cited by 278

The efficacy and safety of sertraline versus imipramine in outpatients with major depression: a six month double-blind, parallel multicenter study

Fontaine, R. (1991) · European Neuropsychopharmacology · doi:10.1016/0924-977x(91)90658-h · Cited by 15

Review: selective serotonin reuptake inhibitors are as effective as tricyclic antidepressants overall but may be less effective in some patient subgroups

Nolen, W. A. (2000) · Evidence-Based Mental Health · doi:10.1136/ebmh.3.4.106

Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis

MacGillivray, S., Arroll, B., Hatcher, S., Ogston, S., Reid, I., Sullivan, F., Williams, B., & Crombie, I. (2003) · BMJ · doi:10.1136/bmj.326.7397.1014 · Cited by 265